Related Experiment Video

Updated: Dec 28, 2025

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

7.9K

Novel Mutation Hotspots within Non-Coding Regulatory Regions of the Chronic Lymphocytic Leukemia Genome

Adrián Mosquera Orgueira1,2,3, Beatriz Rodríguez Antelo4,5,6, José Ángel Díaz Arias4,5

  • 1Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain. adrian.mosquera@live.com.

Scientific Reports
|February 14, 2020
PubMed

Insights

Cancer-driving mutations in non-coding DNA are key in chronic lymphocytic leukemia (CLL). Whole genome sequencing identified new mutated regions affecting gene expression, highlighting potential therapeutic targets.

Area of Science:

  • Genomics
  • Cancer Biology
  • Molecular Oncology

Background:

  • Non-coding DNA mutations are emerging as critical drivers of cancer development.
  • Previous studies in chronic lymphocytic leukemia (CLL) identified recurrent mutations in regulatory regions like NOTCH1 and PAX5.
  • Understanding the role of non-coding mutations is crucial for deciphering cancer pathogenesis.

Purpose of the Study:

  • To analyze whole genome sequencing data from the International Cancer Genome Consortium to identify recurrently mutated non-coding regions in CLL.
  • To investigate the association between these non-coding mutations and the expression of nearby genes.
  • To uncover novel regulatory mechanisms and potential therapeutic targets in CLL.

Main Methods:

  • Utilized whole genome sequencing data from the International Cancer Genome Consortium.
  • Focused analysis on regions with previously identified regulatory activity.
  • Correlated mutation status with gene expression data for neighboring genes.

Main Results:

  • Identified numerous recurrently mutated non-coding regions, often located near genes involved in immune and oncogenic pathways.
  • Detected significant transcriptional changes in genes such as PHF2 and S1PR2, linked to nearby mutations.
  • Highlighted the potential impact of mutations in intergenic regions on gene regulation.

Conclusions:

  • Recurrent non-coding mutations are prevalent in CLL and can influence gene expression.
  • These mutations may play a significant role in immune and oncogenic pathways relevant to CLL.
  • Further research is necessary to elucidate the functional consequences of these non-coding mutations, especially in intergenic areas.

More Related Videos

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

22.2K
Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients13:21

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

10.4K

Related Concept Videos

Histone Variants at the Centromere02:30

Histone Variants at the Centromere

Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.9K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.4K
Chromatin Position Affects Gene Expression02:35

Chromatin Position Affects Gene Expression

Chromatin is the massive complex of DNA and proteins packaged inside the nucleus. The complexity of chromatin folding and how it is packaged inside the nucleus greatly influences  access to genetic information. Generally, the nucleus' periphery is considered transcriptionally repressive, while the cell's interior is considered a transcriptionally active area. 
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
24.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K